Stay updated on ED-SCLC Immuno-Therapy Clinical Trial
Sign up to get notified when there's something new on the ED-SCLC Immuno-Therapy Clinical Trial page.

Latest updates to the ED-SCLC Immuno-Therapy Clinical Trial page
- Check6 days agoChange DetectedA sitewide NIH announcement about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the ClinicalTrials.gov error page.SummaryDifference1%

- Check13 days agoChange DetectedThe footer’s site revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check20 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check41 days agoChange DetectedAccess to the study record is blocked, and the page now displays a 403 Forbidden message with a minimal header and a Home link. Previous study-related sections and metadata have been removed or hidden, replacing the detailed content with the error page.SummaryDifference18%

- Check62 days agoChange DetectedA new Revision: v3.6.6 tag has been added to the page. The earlier Revision: v3.6.5 entry and several related topics (Lung cancer, related topics:, MedlinePlus Genetics) have been removed from the page.SummaryDifference0.1%

- Check69 days agoChange DetectedAdded 2015 ( U.S. NIH Grant/Contract ) as a funding reference and included related topic tags Lung cancer and MedlinePlus Genetics to the study record. These changes serve as metadata to aid indexing and contextual understanding of the study.SummaryDifference0.1%

Stay in the know with updates to ED-SCLC Immuno-Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ED-SCLC Immuno-Therapy Clinical Trial page.